Alto Neuroscience, Inc.
- Last sale
- Nov 12, 2026 · -2.21%
- Market cap
- $1.22B
- 40.11M shares
- Filings
- 199
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+4.9% FY25 yoy
- $1.22B
- —
- —
- 4.1×
- -4.23%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $45,619,000 | reported | |
| FY 2024 | 2024-12-31 | $46,996,000 | reported | |
| FY 2023 | 2023-12-31 | $30,291,000 | reported |
Pharmaceutical preparations
Alto Neuroscience, Inc. is the 137th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
OMEROmeros Corp———$1.3BURGNUroGen Pharma Ltd.$109.8M21.4%139.8%$1.3BCMPSCOMPASS Pathways plc———$1.3BNKTRNektar Therapeutics$55.2M43.9%297.1%$1.3BSNDXSyndax Pharmaceuticals Inc$172.4M627.8%165.6%$1.3BLBRXLB Pharmaceuticals Inc———$1.3BOPKOpko Health, Inc.$606.9M14.9%37.2%$1.2B
ANROAlto Neuroscience, Inc. (this company)———$1.2B
AMPHAmphastar Pharmaceuticals, Inc.$719.9M1.7%13.6%$1.2BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Alto Neuroscience, Inc. · CIK 1999480 · Engraved from SEC EDGAR